The 3rd Crick International Cancer Conference will take place as a hybrid event on the 4-5 October.

This biennial event will explore Cancer at the cell, tissue, and organism level; focusing on the myriad of cell-cell interactions that determine the course of the disease in patients. Headline topics will include metastasis, local and systemic interactions with the immune system, and metabolism.

The conference will be one of the first major events hosted at the Crick since the pandemic which will see a return to in person attendance, and will give us back the networking opportunities that we have missed over the past eighteen months. We are working hard to ensure that the event will be safe and enjoyable for all our attendees.

We recognise it is still difficult for people to travel so there are free virtual tickets for those unable to attend in person. Zoom details and the full joining information will be released nearer the time.

We are offering free two day in-person places for Crick Early Career researchers who submit an abstract. Everyone else should register for the 2 day in person ticket which includes refreshments.There will be an opportunity for people to drop in to sessions of interest if there is space.

If you are a current Crick staff member, and would like to contribute to the conference, please submit abstracts for short talks within the conference programme and for poster sessions using the abstract form found on Crick Net. This is a great opportunity to present at an international meeting alongside world leading PIs.

We are hugely grateful to our sponsors : Amgen, Biotechne,Fluidigm, MedChemExpress, Miltenyi Biotec, Nanostring, PCR Biosystems, Perkinelmer and Zeiss, most of whom will be at the conference in person in the Gallery exhibition and networking space; some will be hosting lunchtime workshops which will be open to all interested Crick staff so please make time to meet with them.

We look forward to seeing you in October.  

Use the conference hashtag #CrickCancerConf

Schedule:

Monday

Session one: focuses on the local microenvironment of primary tumours. Topics likely to be covered include the influence of the extracellular matrix and myeloid cells on cancer cell behaviour and epithelial to mesenchymal transitions.

Session two: will address the process of metastasis from primary to secondary site. Topics will include the pre-metastatic niche, cancer dormancy, and how ageing influences the tumour microenvironment.

Day one concludes with a keynote from Doug Hanahan, a pioneer in mouse models of cancer and tumour – stroma interactions, including with the nervous system and a poster session with networking drinks.

Tuesday

Session three: will explore how metastatic disease responds to therapy. Topics likely to be covered include inter-metastasis heterogeneity within individual patients, monitoring metastatic disease progression via the blood, and systemic effects of therapy on the immune system.

Session four: the meeting will conclude with consideration of the systemic and metabolic consequence of cancer. Focus will be on intra-tumour heterogeneity in metabolism and cachexia.

Both days will include lunchtime sponsor workshops alongside dedicated poster sessions.